Navigation Links
Scientists in Hungary and Portugal get research boost
Date:7/29/2008

Heidelberg, 29 July 2008 Two talented life scientists will receive EMBO Installation Grants, assisting them to establish their research groups in Hungary and Portugal. These two scientists will receive funding in 2008 similar to the previous nine awardees announced in November 2007. The European Molecular Biology Organization (EMBO) introduced the scheme in 2006.

EMBO Installation Grants are awarded annually and aim to strengthen science in selected member states of the EMBC, the EMBO intergovernmental funding body. The EMBC Member States hosting the grantees generally finance the grants entirely. EMBC Member States participating in the scheme include Croatia, the Czech Republic, Estonia, Hungary, Poland, Portugal and Turkey.

Each scientist receives 50,000 euro annually for three to five years to help them establish their groups and themselves in the European scientific community. Grantees are integrated into the prestigious EMBO Young Investigator network, providing networking opportunities with some of Europe's best young group leaders and a range of career development programmes.

"EMBO congratulates these two scientists as recipients of the 2007 EMBO Installation Grants and welcomes them to the EMBO community," said Hermann Bujard, EMBO Executive Director. "These talented scientists will benefit from the secure financial backing of their host countries plus the active interest and support of EMBO in their scientific and professional development. They represent a promising scientific future for the countries receiving them and for Europe as a whole."

A committee of EMBO Members selected the successful candidates for the high standard of their research. By bringing this level of scientific talent into the participating countries, EMBO hopes to improve the competitiveness of these countries in European science.

Gergely Szakcs is moving from the USA to set up his laboratory at the Hungarian Academy of Sciences in Budapest, Hungary to research multidrug resistance in cancer. Szakcs is the third awardee to establish a lab in Hungary of the total 11 scientists receiving the 2007 EMBO Installation Grants.

In Portugal, Monica Bettencourt-Dias's group is researching cell cycle links to cancer at the Gulbenkian Institute in Oeiras. Bettencourt-Dias moves from the UK and is the second awardee to set up in Portugal of the 11 grantees for 2007. Portugal's Foundation for Science & Technology (FCT) and the Gulbenkian Institute will share payment of the Dias grant. Recipients of the 2008 EMBO Installation Grants will be announced in November 2008.


'/>"/>

Contact: Suzanne Beveridge
communications@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Related biology news :

1. Scientists break record by finding northernmost hydrothermal vent field
2. Scientists suspect omega-3 fatty acids could slow acute wound healing
3. Durham scientists to tackle CO2 storage in global warming challenge
4. Licking your wounds: Scientists isolate compound in human saliva that speeds wound healing
5. Training future scientists at the Ecological Society of Americas 93rd Annual Meeting
6. Gladstone scientists create Wikipathways to foster research collaboration
7. Nature publishes new evidence about the deep biosphere written by biogeoscientists
8. ASBMB taps 8 scientists for top awards
9. When fish talk, scientists listen
10. Scientists demonstrate the sharpest measurement of ice crystals in clouds
11. Scientists demonstrate means of reducing Alzheimers-like plaques in fly brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, former senior ... the University of North Carolina Kenan-Flagler Business School effective June 27. ... Kenan-Flagler, with a focus on the school’s international efforts, leading classes and participating ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
Breaking Biology Technology: